idoxuridine has been researched along with Carcinoma, Epidermoid in 27 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Twenty patients with squamous cell carcinomas of the head and neck treated with primary surgery were injected with pimonidazole and IdUrd the evening before operation." | 5.31 | HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors. ( Balm, AJ; Begg, AC; Blijweert, E; Blommestijn, G; Delaere, P; Haustermans, KM; Hoebers, FJ; Hofland, I; Janssen, HL; Raleigh, JA; Sciot, R; Semenza, GL; Sprong, D; van Velthuysen, ML; Varia, MA, 2002) |
| "Seven patients with colorectal adenocarcinoma and one with squamous cell carcinoma of anorectal region were infused preoperatively with iododeoxyuridine (IUdR) and bromodeoxyuridine (BrdU) in sequence (100 mg/m2 x 1 hr each with 1-hr interval in between) to label S-phase cells." | 3.68 | Cell cycle parameters and DNA ploidy in colorectal carcinomas. ( Bokhari, J; Hyams, D; Khan, S; Raza, A; Sheikh, Y; Yousuf, N, 1991) |
| "Seventeen patients with primary squamous cell carcinomas of the oral cavity underwent an (18)F-FLT PET/CT scan before surgery, and iododeoxyuridine was administered 20 min before tumor resection." | 1.36 | Histopathologic validation of 3'-deoxy-3'-18F-fluorothymidine PET in squamous cell carcinoma of the oral cavity. ( Bussink, J; Kaanders, JH; Merkx, MA; Oyen, WJ; Peeters, WJ; Slootweg, PJ; Troost, EG; van der Kogel, AJ, 2010) |
| "Twenty patients with squamous cell carcinomas of the head and neck treated with primary surgery were injected with pimonidazole and IdUrd the evening before operation." | 1.31 | HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors. ( Balm, AJ; Begg, AC; Blijweert, E; Blommestijn, G; Delaere, P; Haustermans, KM; Hoebers, FJ; Hofland, I; Janssen, HL; Raleigh, JA; Sciot, R; Semenza, GL; Sprong, D; van Velthuysen, ML; Varia, MA, 2002) |
| "33 patients with head and neck cancer were administered iododeoxyuridine (IdUrd) prior to treatment and a second administration of bromodeoxyuridine (BrdUrd) prior to the fifth fraction of 2 Gy." | 1.31 | Cell kinetic changes in human squamous cell carcinomas during radiotherapy studied using the in vivo administration of two halogenated pyrimidines. ( Flygare, P; Gustafsson, H; Sjöström, B; Wilson, GD; Zackrisson, B, 2002) |
| "It can be concluded that the linear-quadratic analysis of dose-response relationships offers insights into the correlation between cell survival and induction of exchanges in non-sensitized and radiosensitized cells." | 1.30 | Correlation between cell reproductive death and chromosome aberrations assessed by FISH for low and high doses of radiation and sensitization by iodo-deoxyuridine in human SW-1573 cells. ( Barendsen, GW; Darroudi, F; Franken, NA; Kipp, JB; Ludwików, G; Ruurs, P; van Bree, C, 1999) |
| "Tumorigenicity, production of distant metastases and survival were recorded." | 1.28 | Intrabronchial implantation of the Lewis lung tumor cell does not favor tumorigenicity and metastasis. ( Fidler, IJ; Li, LM; Shin, DM, 1990) |
| "(125I) Iododeoxyuridine labeling of a squamous cell carcinoma and follow-up of 125I activity at the tumor in situ revealed that the 125I activity remained at a constant level from the 24th to the 100th hour post-labeling and then decreased with a half time of about 200 hr." | 1.28 | [Transition of oxic cells to hypoxic cells in a murine squamous cell carcinoma]. ( Takai, Y, 1989) |
| "[125I]Iododeoxyuridine labeling of a squamous cell carcinoma and follow-up of 125I activity at the tumor in situ revealed that the 125I activity remained at a constant level from the 24th to the 100th hour post-labeling and then decreased with a half time of about 200 hr." | 1.27 | Oxic and hypoxic cells in a murine squamous cell carcinoma. ( Okada, S; Sakamoto, K; Takai, Y, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (33.33) | 18.7374 |
| 1990's | 10 (37.04) | 18.2507 |
| 2000's | 7 (25.93) | 29.6817 |
| 2010's | 1 (3.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Troost, EG | 1 |
| Bussink, J | 1 |
| Slootweg, PJ | 1 |
| Peeters, WJ | 1 |
| Merkx, MA | 1 |
| van der Kogel, AJ | 2 |
| Oyen, WJ | 1 |
| Kaanders, JH | 2 |
| Janssen, HL | 1 |
| Haustermans, KM | 1 |
| Sprong, D | 1 |
| Blommestijn, G | 1 |
| Hofland, I | 2 |
| Hoebers, FJ | 1 |
| Blijweert, E | 1 |
| Raleigh, JA | 1 |
| Semenza, GL | 1 |
| Varia, MA | 1 |
| Balm, AJ | 1 |
| van Velthuysen, ML | 1 |
| Delaere, P | 1 |
| Sciot, R | 1 |
| Begg, AC | 2 |
| CALABRESI, P | 1 |
| CREASEY, WA | 1 |
| PRUSOFF, H | 1 |
| WELCH, AD | 1 |
| JOHNSON, RO | 1 |
| KISKEN, WA | 1 |
| CURRERI, AR | 1 |
| Harrington, KJ | 1 |
| Syrigos, KN | 1 |
| Uster, PS | 1 |
| Zetter, A | 1 |
| Lewanski, CR | 1 |
| Gullick, WJ | 1 |
| Vile, RG | 1 |
| Stewart, JS | 1 |
| Corde, S | 1 |
| Joubert, A | 1 |
| Adam, JF | 1 |
| Charvet, AM | 1 |
| Le Bas, JF | 1 |
| Estève, F | 1 |
| Elleaume, H | 1 |
| Balosso, J | 1 |
| Wijffels, KI | 1 |
| Marres, HA | 1 |
| Peters, JP | 1 |
| Rijken, PF | 1 |
| Koppang, HS | 1 |
| Aas, E | 1 |
| Kotelnikov, VM | 2 |
| Coon, JS | 2 |
| Taylor, S | 1 |
| Hutchinson, J | 2 |
| Panje, W | 2 |
| Caldarelli, DD | 2 |
| LaFollette, S | 1 |
| Preisler, HD | 3 |
| Perez, LA | 1 |
| Dombkowski, D | 1 |
| Efird, J | 1 |
| Preffer, F | 1 |
| Suit, HD | 1 |
| Høyer, M | 1 |
| Jørgensen, K | 1 |
| Bundgaard, T | 1 |
| Johansen, LV | 1 |
| Bentzen, SM | 1 |
| Overgaard, M | 1 |
| Hansen, O | 1 |
| Søgaard, H | 1 |
| Overgaard, J | 1 |
| Takai, Y | 3 |
| Hosoi, Y | 1 |
| Sakamoto, K | 2 |
| Okada, S | 2 |
| Epstein, AH | 1 |
| Lebovics, RS | 1 |
| Van Waes, C | 1 |
| Smith, J | 1 |
| Okunieff, P | 1 |
| Cook, JA | 1 |
| Kotelnikov, V | 1 |
| Cass, L | 1 |
| Spaulding, D | 1 |
| Coon JS, IV | 1 |
| Haleem, A | 1 |
| Taylor S, IV | 1 |
| Griem, K | 1 |
| Franken, NA | 1 |
| Ruurs, P | 1 |
| Ludwików, G | 1 |
| van Bree, C | 1 |
| Kipp, JB | 1 |
| Darroudi, F | 1 |
| Barendsen, GW | 1 |
| Lotayef, M | 1 |
| Wilson, GD | 2 |
| Daley, FM | 1 |
| Awwad, HK | 1 |
| Shouman, T | 1 |
| Haustermans, K | 1 |
| Fowler, JF | 1 |
| Zackrisson, B | 1 |
| Flygare, P | 1 |
| Gustafsson, H | 1 |
| Sjöström, B | 1 |
| Yousuf, N | 1 |
| Khan, S | 1 |
| Sheikh, Y | 1 |
| Hyams, D | 1 |
| Bokhari, J | 1 |
| Raza, A | 1 |
| Li, LM | 1 |
| Shin, DM | 1 |
| Fidler, IJ | 1 |
| Sato, H | 1 |
| Takimoto, T | 1 |
| Tanaka, S | 1 |
| Ogura, H | 1 |
| Shiraishi, K | 1 |
| Tanaka, J | 1 |
| Moonen, L | 1 |
| Dessing, M | 1 |
| Bartelink, H | 1 |
| Goffinet, DR | 1 |
| Bagshaw, MA | 1 |
| Fox, EC | 1 |
2 reviews available for idoxuridine and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Clinical use of radiation sensitizing agents.
Topics: Animals; Antimetabolites, Antineoplastic; Bleomycin; Bromodeoxycytidine; Bromodeoxyuridine; Bromoura | 1974 |
The problem or oral ulcerations in general practice with special reference to herpetic herpetiform lesions.
Topics: Adult; Carcinoma, Squamous Cell; Family Practice; Female; Gingivitis; Gingivitis, Necrotizing Ulcera | 1970 |
2 trials available for idoxuridine and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Intravenous delivery of 5'-iododeoxyuridine during hyperfractionated radiotherapy for locally advanced head and neck cancers: results of a pilot study.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease-Free Survival; Dose Fracti | 1998 |
Aberrant expression of cyclin A in head and neck cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Cell Cycle; Combined Modality Therapy; Cyclin A; Female; Gene | 2000 |
23 other studies available for idoxuridine and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Histopathologic validation of 3'-deoxy-3'-18F-fluorothymidine PET in squamous cell carcinoma of the oral cavity.
Topics: Biomarkers; Carcinoma, Squamous Cell; Dideoxynucleosides; Female; Humans; Idoxuridine; Image Process | 2010 |
HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors.
Topics: Carcinoma, Squamous Cell; Dimerization; Dose-Response Relationship, Drug; Head and Neck Neoplasms; H | 2002 |
Clinical and pharmacological studies with 5-iodo-2'-deoxycytidine.
Topics: Adenocarcinoma; Bromodeoxycytidine; Carcinoma; Carcinoma, Squamous Cell; Deoxycytidine; Hodgkin Dise | 1963 |
SQUAMOUS CELL CARCINOMA OF ORAL CAVITY; INTRA-ARTERIAL INFUSION WITH FLUOROURACIL AND IDOXURIDINE.
Topics: Carcinoma; Carcinoma, Squamous Cell; Drug Therapy; Fluorouracil; Humans; Idoxuridine; Infusions, Int | 1965 |
Targeted radiosensitisation by pegylated liposome-encapsulated 3', 5'-O-dipalmitoyl 5-iodo-2'-deoxyuridine in a head and neck cancer xenograft model.
Topics: Animals; Carcinoma, Squamous Cell; Dose-Response Relationship, Radiation; Drug Carriers; Female; Hea | 2004 |
Synchrotron radiation-based experimental determination of the optimal energy for cell radiotoxicity enhancement following photoelectric effect on stable iodinated compounds.
Topics: Carcinoma, Squamous Cell; Cell Death; Cell Survival; Contrast Media; Head and Neck Neoplasms; Humans | 2004 |
Tumour cell proliferation under hypoxic conditions in human head and neck squamous cell carcinomas.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Proliferation; | 2008 |
Squamous carcinoma induced by topical idoxuridine therapy?
Topics: Adult; Carcinoma, Squamous Cell; Female; Humans; Idoxuridine; Lip Neoplasms | 1983 |
In vivo labelling with halogenated pyrimidines of squamous cell carcinomas and adjacent non-involved mucosa of head and neck region.
Topics: Biomarkers, Tumor; Biopsy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Epithelial Cells; Head and N | 1995 |
Cell proliferation kinetics in human tumor xenografts measured with iododeoxyuridine labeling and flow cytometry: a study of heterogeneity and a comparison between different methods of calculation and other proliferation measurements.
Topics: Animals; Carcinoma, Squamous Cell; Cell Count; Cell Division; Colorectal Neoplasms; DNA, Neoplasm; F | 1995 |
Lack of predictive value of potential doubling time and iododeoxyuridine labelling index in radiotherapy of squamous cell carcinoma of the head and neck.
Topics: Analysis of Variance; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; DNA, Neoplasm; Head and N | 1998 |
Single dose radiocurability of four murine solid tumors and a predictive assay for the curability in situ.
Topics: Animals; Carcinoma, Squamous Cell; Female; Fibrosarcoma; Idoxuridine; Iodine Radioisotopes; Male; Mi | 1997 |
Accuracy of histone H3 messenger RNA in situ hybridization for the assessment of cell proliferation in human tissues.
Topics: Biopsy; Carcinoma, Squamous Cell; Cell Division; Head and Neck Neoplasms; Histones; Humans; Idoxurid | 1997 |
Cell kinetics of head and neck cancers.
Topics: Biopsy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; DNA, Neoplasm; G2 Ph | 1995 |
Correlation between cell reproductive death and chromosome aberrations assessed by FISH for low and high doses of radiation and sensitization by iodo-deoxyuridine in human SW-1573 cells.
Topics: Carcinoma, Squamous Cell; Cell Death; Cell Division; Cell Survival; Chromosome Aberrations; Chromoso | 1999 |
Is there a future for cell kinetic measurements using IdUrd or BdUrd?
Topics: Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; DNA, Neoplasm; Esophageal Neoplasms; Fol | 2001 |
Cell kinetic changes in human squamous cell carcinomas during radiotherapy studied using the in vivo administration of two halogenated pyrimidines.
Topics: Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Feasibility Studies; Female; | 2002 |
Cell cycle parameters and DNA ploidy in colorectal carcinomas.
Topics: Adenocarcinoma; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Colorectal Neoplasms; DNA; | 1991 |
Intrabronchial implantation of the Lewis lung tumor cell does not favor tumorigenicity and metastasis.
Topics: Animals; Bronchial Neoplasms; Carcinoma, Squamous Cell; Female; Humans; Idoxuridine; Injections, Int | 1990 |
Cytopathic effects induced by Epstein-Barr virus replication in epithelial nasopharyngeal carcinoma hybrid cells.
Topics: Acyclovir; Antigens, Viral; Carcinoma, Squamous Cell; Cell Fusion; Cytopathogenic Effect, Viral; Deo | 1989 |
[Transition of oxic cells to hypoxic cells in a murine squamous cell carcinoma].
Topics: Animals; Autoradiography; Carcinoma, Squamous Cell; Cell Hypoxia; Idoxuridine; Iodine Radioisotopes; | 1989 |
Oxic and hypoxic cells in a murine squamous cell carcinoma.
Topics: Animals; Carcinoma, Squamous Cell; Constriction; Dose-Response Relationship, Radiation; Female; Hypo | 1988 |
Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine: intratumour sampling variations.
Topics: Antibodies, Monoclonal; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cell Cycle; DNA, Neo | 1988 |